Seokho Yun

Seokho Yun

Auto-generated profile, based on publicly available information

Seokho Yun

Department of Psychiatry, Yeungnam University Hospital, Daegu, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2021 in Journal of Yeungnam Medical Science
Verified
Journal Article
Open access
PDF file
SJSo-Hye Jo
So-Hye Jo
SKSuk-Hun Kang
Suk-Hun Kang
WSWan-Seok Seo
Wan-Seok Seo
BKBon-Hoon Koo
Bon-Hoon Koo
HKHye Geum Kim
Hye Geum Kim
SYSeok-Ho Yun
Seok-Ho Yun
Amputation changes the lives of patients and their families. Consequently, the patient must adapt to altered body function and image. During this adaptation process, psychological problems, such as depression, anxiety, and posttraumatic stress disorder, can occur. The psychological difficulties of patients with amputation are often accepted as normal responses that are often poorly recognized by patients, family members, and their primary physicians. Psychological problems can interfere with rehabilitation and cause additional psychosocial problems. Therefore, their early detection and treatment are important. A multidisciplinary team approach, including mental health professionals, is ideal for comprehensive and biopsychosocial management. Mental health professionals could help patients set realistic goals and use adaptive coping styles. Psychiatric approaches should consider the physical, cognitive, psychological, social, and spiritual functions and social support systems before and after amputation. The abilities and limitations of physical, cognitive, psychological, and social functions should also be considered. To improve the patient's adaptation, psychological interventions such as short-term psychotherapy, cognitive behavioral therapy, mindfulness meditation, biofeedback, and group psychotherapy can be helpful.

31 October 2024 in Journal of Yeungnam Medical Science
Verified
Journal Article
Open access
SYSeokho Yun
Seokho Yun
Owing to a lack of appropriate biomarkers for accurate diagnosis and treatment, psychiatric disorders cause significant distress and functional impairment, leading to social and economic losses. Biomarkers are essential for diagnosing, predicting, treating, and monitoring various diseases. However, their absence in psychiatry is linked to the complex structure of the brain and the lack of direct monitoring modalities. This review examines the potential of electroencephalography (EEG) as a neurophysiological tool for identifying psychiatric biomarkers. EEG noninvasively measures brain electrophysiological activity and is used to diagnose neurological disorders, such as depression, bipolar disorder (BD), and schizophrenia, and identify psychiatric biomarkers. Despite extensive research, EEG-based biomarkers have not been clinically utilized owing to measurement and analysis constraints. EEG studies have revealed spectral and complexity measures for depression, brainwave abnormalities in BD, and power spectral abnormalities in schizophrenia. However, no EEG-based biomarkers are currently used clinically for the treatment of psychiatric disorders. The advantages of EEG include real-time data acquisition, noninvasiveness, cost-effectiveness, and high temporal resolution. Challenges such as low spatial resolution, susceptibility to interference, and complexity of data interpretation limit its clinical application. Integrating EEG with other neuroimaging techniques, advanced signal processing, and standardized protocols is essential to overcome these limitations. Artificial intelligence may enhance EEG analysis and biomarker discovery, potentially transforming psychiatric care by providing early diagnosis, personalized treatment, and improved disease progression monitoring.

1 August 2021 in Clinical Neurophysiology
Verified
Journal Article
Closed access
SYSeokho Yun
Seokho Yun
BJBumseok Jeong
Bumseok Jeong

1 September 2019
Verified
Conference Paper
Closed access
SLSangmin Lee
Sangmin Lee
SKSeongyeop Kim
Seongyeop Kim
HKHak Gu Kim
Hak Gu Kim
MKMin Seob Kim
Min Seob Kim
SYSeokho Yun
Seokho Yun
YRYong Man Ro
Yong Man Ro
Quantifying Virtual Reality (VR) sickness is demanded in industry to address viewing safety issue. In this paper, we develop a new method to quantify VR sickness. We propose a novel physiological fusion deep network which estimates individual VR sickness with content stimulus and physiological response. In the proposed framework, content stimulus guider and physiological response guider are devised to effectively represent feature related with VR sickness. Deep stimulus feature from the content stimulus guiders reflects the content sickness tendency while deep physiology feature from the physiological response guider reflects the individual sickness characteristics. By combining those features, VR sickness predictor quantifies individual Simulation Sickness Questionnaires (SSQ) scores. To evaluate the performance of the proposed method, we built a new dataset that consists of 360-degree videos with physiological signals and SSQ scores. Experimental results show that the proposed method achieved meaningful correlation with human subjective scores.

31 October 2021 in Journal of Yeungnam Medical Science
Verified
Journal Article
Open access
PDF file
SYSeokho Yun
Seokho Yun
SJSohye Jo
Sohye Jo
Sleep plays a critical role in homeostasis of the body and mind. Insomnia is a disease that causes disturbances in the initiation and maintenance of sleep. Insomnia is known to affect not only the sleep process itself but also an individual’s cognitive function and emotional regulation during the daytime. It increases the risk of various neuropsychiatric diseases such as depression, anxiety disorder, and dementia. Although it might appear that insomnia only affects the nervous system, it is also a systemic disease that affects several aspects of the body, such as the cardiovascular, endocrine, and immune systems; therefore, it increases the risk of various diseases such as hypertension, diabetes mellitus, and infection. Insomnia has a wide range of effects on our bodies because sleep is a complex and active process. However, a high proportion of patients with insomnia do not seek treatment, which results in high direct and indirect costs. This is attributed to the disregard of many of the negative effects of insomnia. Therefore, we expect that understanding insomnia as a systemic disease will provide an opportunity to understand the condition better and help prevent secondary impairment due to insomnia.

1 January 2025 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HKHye Geum Kim
Hye Geum Kim
DBDai Seg Bai
Dai Seg Bai
BKBon-Hoon Koo
Bon-Hoon Koo
ECEun-Jin Cheon
Eun-Jin Cheon
SYSeokho Yun
Seokho Yun
Byoungyoung GuByoungyoung Gu
Byoungyoung Gu
Kim HG, et al. J Korean Med Sci. 2024 Nov;40:e20. https://doi.org/10.3346/jkms.2025.40.e20